OncoMouse
Definition
OncoMouse is both a noun and a trademark. It is a term used to describe a transgenic mouse carrying an activated human cancer gene, used in laboratory experiments.[1] Oncomouse was engineered with a pump attached to its body in order to understand how to manage human life in long term space travel. Klines and Cline had a quite Positive view on the ideas of the future of space travel. Humans, space, drugs. Environment To surmount the everyday conditions of reality in order to ameliorate the symptoms of everyday reality.[2] OncoMouse also the first patented animal. Two patents were awarded to Harvard College that covered methods for providing a cell culture from a transgenic non-human animal.[3]
The OncoMouse is a mouse with a pump attached to it that can administer OncoMouse is a term used to describe (a type of laboratory mouse that has been genetically modified using modifications designed by Philip Leder and Timothy A Stewart[4] of Harvard University to carry a specific gene called an activated oncogene. The activated oncogene significantly increases the mouse’s susceptibility to cancer, and thus makes the mouse suitable for cancer research. The rights to the invention are owned by DuPont. "OncoMouse" is a registered trademark.[5]) http://en.wikipedia.org/wiki/Oncomouse
References
- ↑ New Oxford American Dictionary
- ↑ Gray, Chris Hables, ed. The Cyborg Handbook. New York: Routledge, 1995.
- ↑ U.S. Patent 5,087,571; filed Mar 22, 1988, issued Feb 11, 1992, expired Feb 11, 2009) and testing methods using transgenic mice expressing an oncogene, U.S. Patent 5,925,803; filed Sep 19, 1991, issued Jul 20, 1999, expires July 20, 2016.
- ↑ European Patent Register entry for European patent no. 0169672, under "Inventor(s)". Consulted on February 22, 2008.
- ↑ Trademark: USPTO serial number 75797027
